For animal use only.
Clostrivax B is an adjuvanted multi-component vaccine for the active immunisation of cattle against diseases caused by Clostridium perfringens type A (enterotoxaemia), C. botulinum types C and D (botulism), C. novyi type A (swollen head), C. novyi type B (black disease), C. chauvoei (black quarter), C. sordellii (sudden death syndrome), C. septicum (malignant oedema) and Mannheimia haemolytica type A1 (bovine respiratory disease).
COMPOSITION
Clostrivax B contains toxoids from C. perfringens type A, C. botulinum types C and D, C. novyi types A and B, C. sordellii, C. septicum, M. haemolytica type A1 leukotoxin and formalin inactivated C. chauvoei anacultures.
STORAGE
Store in a refrigerator between 2°C and 8°C. Do not freeze. Protect from high temperatures and direct sunlight. Do not use after the expiry date printed on the container. Do not store any vials into which a needle or other device has been inserted, for future use.
DIRECTIONS FOR USE - USE ONLY AS DIRECTED
- Shake gently before use by inverting the vial several times.
- Use sterile needles and syringes to administer Clostrivax B.
- Inject cattle subcutaneously on the side of the neck. DO NOT deviate from the recommended route and injection site location.
- Calves may be vaccinated from 2 months of age and older.
- Clostrivax B is safe to use in heifers and cows in all trimesters of pregnancy or calves nursing pregnant cows.
- Previously sensitised cows should be vaccinated 2-6 weeks before calving is due to commence. This provides passive protection to the calf, via colostrum, for up to 8 weeks.
DOSAGE
- 2 ml via the subcutaneous route.
- A booster vaccination of 2 ml should be administered 3-4 weeks later. Annual revaccination is recommended thereafter.
PACKING SIZE AND ORDERING CODE
20 ml/20 ds (LVS06744)
100 ml/100 ds (LVS06612)
Reg. no. G4483 (36/1947)
Reg. holder: Vetvax (Pty) Ltd, Reg. no. 2004/035302/07, 442 Rigel Avenue South, Erasmusrand, Pretoria | Tel. 012 349 2772
Clostrivax B
- Withdrawal period: Do not slaughter animals for human consumption within 21 days of vaccination.
- Usually no marked reactions follow vaccination, although a transient swelling may appear at the site of inoculation, and some animals may show a moderate rise of temperature for one or two days.
- Do not use in animal species other than those indicated.
- Do not administer to animals in poor or extremely poor body condition.
- KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
- If failure of this product is suspected, seek veterinary advice and notify the registration holder and the registrar.
- Follow standard sterile procedures during administration of injections.
- Do not mix this product with any other vaccines or medicines.
- Avoid contact with skin, eyes and mouth.
- Do not eat, drink or smoke whilst handling the product.
- Do not contaminate rivers, dams or any water sources with containers or waste.
- Dispose of all containers and all unused contents in accordance with the local law.

